Related Experiment Video
Updated: Jul 17, 2026
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Comparable strategies needed to evaluate human papillomavirus vaccine efficiency across Europe
1Health Protection Agency Centre for Infections, London, United Kingdom. kate.soldan@hpa.org.uk
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
SARS-CoV-2 infections amongst personnel providing home care services for older persons in Stockholm, Sweden.
Journal of internal medicine·2021
Estimates of the frequency of HBV, HCV, and HIV infectious donations entering the blood supply in the United Kingdom, 1996 to 2003.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2017
High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders.
British journal of cancer·2017
Estimation of the Infectious Risks of Blood Transfusion.
Hematology (Amsterdam, Netherlands)·2016
Molecular methods for identification and characterization of novel papillomaviruses.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2015
An outbreak of Panton-Valentine leucocidin-producing meticillin-resistant Staphylococcus aureus skin and soft tissue infection associated with bouncy castle use, Ireland, 2025.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Monitoring of cryptosporidiosis: a shift in circulating Cryptosporidium hominis subtypes, the Netherlands, 2016 to 2024.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Autochthonous chikungunya virus (CHIKV) outbreak in the province of Modena, Emilia-Romagna region, Italy, August to October 2025: epidemiology, clinical features and virological findings.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Early impact of maternal RSV vaccination on bronchiolitis hospitalisation and critical care admissions in infants under age 3 months, England, September 2024 to March 2026.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Multicentre outbreak of Candida viswanathii bloodstream infections linked to contaminated milrinone, Italy, April to October 2025.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Emergence and spread of NA-I223V and NA-S247N double-mutant A(H1N1)pdm09 influenza viruses with reduced oseltamivir susceptibility in the Netherlands and beyond, 2023 to 2026.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
A mark and recapture perspective on vaccination touchpoints.
Gates open research·2026
Management of Erythromelalgia: a narrative review and expert opinion.
Expert opinion on pharmacotherapy·2026
Influenza vaccine effectiveness in patients with chronic obstructive pulmonary disease: a cohort study emulating a randomized trial.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026